UniProtKB/SwissProt variant VAR

Variant information

Variant position:

387

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Leucine (L) at position 387 (P387L, p.Pro387Leu).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic.

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-3

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

Associated with low glucose tolerance.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs16995309 [ dbSNP | Ensembl ]

Sequence information

Variant position:

387

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

435

The length of the canonical sequence.

Location on the sequence:

DTEVRSRVVGGSLRGAQAAS P AKGEPSLPEKDEDHALSYWK

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DTEVRSRVVGGSLRGAQAASPAKGEPSLP-EKDEDHALSYWK

Mouse                         DTEVRRRMVGGGLQSAQASVPTEEELSSTEEEHKAHWPSHW

Rat                           DTEVRKRMVGGGLQSAQASVPTEEELSPTEEEQKAHRPVHW

Chicken                       DTEIRRRTVGENL---HVTAHKEESKSESVEEDDENMMTTW

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 435	Tyrosine-protein phosphatase non-receptor type 1
Region	378 – 398	Disordered
Modified residue	368 – 368	Phosphothreonine
Modified residue	378 – 378	Phosphoserine; by PKC
Modified residue	386 – 386	Phosphoserine; by CDK1

Literature citations

Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism.
Ukkola O.; Rankinen T.; Lakka T.; Leon A.S.; Skinner J.S.; Wilmore J.H.; Rao D.C.; Kesaeniemi Y.A.; Bouchard C.;
Obes. Res. 13:829-834(2005)
Cited for: ASSOCIATION OF VARIANT LEU-387 WITH LOW GLUCOSE TOLERANCE;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P18031: Variant p.Pro387Leu